NVS News & Events

A report led by Senator Bernie Sanders found that prescription drug prices have continued to rise despite prior pricing agreements with Presidnet Donald Trump, with some medications seeing significant increases and new drugs launching at very high annual costs, NBC News' Berkeley Lovelace Jr. reports. The findings highlight ongoing challenges in controlling U.S. drug pricing ahead of a Senate hearing on the issue. Publicly traded companies in the space include AstraZeneca (AZN), Bristol Myers (BMY), Eli Lilly (LLY), GSK (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).

Anthropic has appointed Novartis (NVS) CEO Vas Narasimhan to its board, its second board addition in recent months, as it eyes an IPO and pushes further into health care, The Wall Street Journal's Kate Clark reports. The company added former Microsoft (MSFT) and GM (GM) executive Chris Liddell to its board in February.